3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Gastrointestinal
2
Breast
2
Thoracic
1
Gynecologic
1
Conditions
Breast Neoplasms
12
Colorectal Neoplasms
5
Smoking Cessation
4
Motor Activity
4
Neoplasms
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Endometrial Neoplasms
2
Skin Cancer Prevention
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Melanoma
1
Medication Adherence
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Colonic Neoplasms
1
Chronic Pain
1
Body Weight Changes
1
Body Weight
1
Behavior
1
Anxiety Disorders
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Motivational Interviewing
×
Clear all
NCT05162846
2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA
Completed
831 enrolled
NCT05354882
2023-05-09
DEFACTO2
Université Sorbonne Paris Nord
Phase NA
Unknown
150 enrolled